Four decades of normal pressure hydrocephalus: are we doing better?
Cerebrospinal Fluid Research volume 1, Article number: S61 (2004)
In the UK it is estimated that about 5% patients with dementia above the age of 60 suffer from Normal pressure hydrocephalus (NPH). This 5% could represent up to 24,000 people who may be suitable for assessment for treatment. Awareness of this condition is constantly rising both among doctors and patients. A recognised difficulty is the confirmation of the diagnosis and selection of those patients who will benefit from treatment. Despite emerging knowledge of over 40 years, the results of patient selection and shunt insertion have not improved significantly.
Since the historic paper by Hakim and Adams in 1965, a great deal of further research has accumulated. Patients are currently classified into those whose NPH has a known cause and an idiopathic group (INPH). Table 1 highlights the key research findings so far.
No single test is predictive to determine the shunt responders. Over the years several combinations of tests have been used to predict those who will respond to a shunt operation. Surgery is believed to benefit 50–70% of patients where there is a known cause, and 30–50% where the cause is idiopathic if identified correctly. It is equally important to identify patients unlikely to benefit. Shunting, particularly in elderly patients, is associated with a significant incidence of both acute and cumulative longer-term complication. Only a few papers report the extended follow-up of patients and the value of the predicting factors in the long term. A guide to some of the tests and predictive feature identified in the literature is summarised in Table 2.
Few studies have examined the long-term prognosis for those with treated and untreated NPH. Indeed, the recent Cochrane review (2002) indicated that shunt insertion was ineffective in treating NPH but this may be due to inappropriate comparison groups and lack of class 1 evidence. Tests revolving around CSF lumbar puncture, lumbar tap and drainage have been the main stay of assessing likelihood to respond to treatment. But, how reliable is this in predicting outcome? Since the disease is complex and there may not be a gold standard test to predict shunt response, future efforts should be directed towards better identification of the pathogenesis of idiopathic NPH.
Many CSF factors have been identify that can diagnose the disease and predict outcome. MR CSF flow studies can predict shunt responders and PET scans have been used to detect peri-ventricular blood flow improvement post shunt. Non-invasive methods of investigation and prediction of outcome is being increasingly recognised. Treatment has been challenged with ventriculostomy. Thus, it is clear that further work needs to be conducted to ascertain the best way of diagnosing patients likely to benefit from surgery.
About this article
Cite this article
Balamurali, G., Golash, A. & Starkey, N. Four decades of normal pressure hydrocephalus: are we doing better?. Fluids Barriers CNS 1 (Suppl 1), S61 (2004). https://doi.org/10.1186/1743-8454-1-S1-S61
- Historic Paper
- Normal Pressure Hydrocephalus
- Recent Cochrane Review
- Normal Pressure Hydrocephalus
- Gold Standard Test